MedPath

Clobetasol Propionate

Clobetasol Propionate Ointment USP, 0.05% Rx only FOR TOPICAL DERMATOLOGIC USE ONLY  NOT FOR OPHTHALMIC, ORAL OR INTRAVAGINAL USE.

Approved
Approval ID

1f076779-3f76-47d5-99f0-9b0b2d3f5fac

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 22, 2023

Manufacturers
FDA

Encube Ethicals Private Limited

DUNS: 915834105

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Clobetasol Propionate Ointment USP, 0.05%

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21922-017
Application NumberANDA211295
Product Classification
M
Marketing Category
C73584
G
Generic Name
Clobetasol Propionate Ointment USP, 0.05%
Product Specifications
Route of AdministrationTOPICAL
Effective DateDecember 22, 2023
FDA Product Classification

INGREDIENTS (4)

CLOBETASOL PROPIONATEActive
Quantity: 0.5 mg in 1 g
Code: 779619577M
Classification: ACTIB
SORBITAN SESQUIOLEATEInactive
Code: 0W8RRI5W5A
Classification: IACT
PETROLATUMInactive
Code: 4T6H12BN9U
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Clobetasol Propionate - FDA Drug Approval Details